Healthcare technology company Mendaera has secured $73m in a Series B financing round, with the investment to be used for expanding the use of robotics and AI in mainstream medical procedures.

Threshold Ventures led the funding round, which saw contributions from Lux Capital, PFM Health Sciences, and Intuitive Surgical and Auris Health founder Fred Moll.

The capital injection will enable Mendaera to advance its mission of making complex technologies available for foundational medical procedures.

The company will focus on refining a handheld robotic interventional platform that integrates robotics, AI, real-time imaging, and virtual connectivity.

This platform is designed to be widely accessible, enhancing the capabilities of healthcare providers across various specialities and service sites.

The newly acquired funds will be allocated to completing the development of Mendaera's robotic technology, expediting the advancement of its AI and connectivity features, and initiating the clinical introduction of its new platform.

Mendaera founder and CEO Josh DeFonzo said: “Traditional surgical robots have established footing in the operating room. But robotics and AI have evolved to a point where we can deliver broader benefits across all parts of the healthcare system and enable higher standards of care for more patients.

“We believe that our technology will allow healthcare systems and providers to provision medical procedures at scale, enhancing patient experience, increasing access to high-quality care, reducing overall cost, and improving healthcare provider satisfaction.”

The company expanded its technology portfolio earlier in the year through the acquisition of telepresence technology from Avail Medsystems.

Last year, Mendaera entered a commercial agreement with Butterfly Network, an enterprise specialising in point-of-care ultrasound technology, for the commercialisation of a next-generation interventional robotic system.